Ac2-26 has been shown to regulate leukocytes and other tumor cell migratory events through interactions with formyl peptide receptors (FPRs), and thus we examined the expression of FPR1, FPR2, and FPR3 in BC cells by RT-qPCR. This evidence concerns the gene FPR3 and breast cancer.